Brandie D Taylor1, Roberta B Ness2, Mark A Klebanoff3, Gong Tang4, James M Roberts5, David M Hougaard6, Kristin Skogstrand6, Catherine L Haggerty7. 1. Department of Epidemiology and Biostatistics, Texas A&M University, School of Public Health, College Station, TX, USA. Electronic address: Taylor@sph.tamhsc.edu. 2. University of Texas School of Public Health, Houston, TX, USA. 3. The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. 4. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. 5. Magee-Womens Research Institute, Department of Obstetrics and Gynecology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. 6. Danish Centre for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark. 7. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
OBJECTIVE: Small studies suggest that fetal sex alters maternal inflammation. We examined the association between fetal sex, preeclampsia and circulating maternal immune markers. METHODS: This was a secondary data analysis within a nested case-control study of 216 preeclamptic women and 432 randomly selected normotensive controls from the Collaborative Perinatal Project. All women had singleton, primiparous pregnancies without chronic health conditions. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for associations between female fetal sex and preeclampsia. Outcomes included preeclampsia, preterm preeclampsia (<37 and <34 weeks), and normotensive preterm birth <37 weeks. Associations between female fetal sex and immune markers [interleukin (IL)-6, IL4, IL5, IL12, IL10, IL8, IL1-beta, interferon (IFN)-gamma, tumor necrosis factor (TNF)-beta, and transforming growth factor-beta] were examined using a statistical method developed for large proportions of censored biomarker data. Models were adjusted for maternal age, race, body mass index, and smoking. RESULTS: Women with early preterm preeclampsia (<34 weeks) had higher odds of having a female fetus (ORadj. 3.2, 95% CI 1.1-9.6) and women with normotensive preterm birth had lower odds (ORadj. 0.5, 95% CI 0.3-0.9). Female fetal sex was associated with lower first trimester pro-inflammatory IFNγ and IL-12 but higher second trimester pro-inflammatory IL1β and TNFβ, anti-inflammatory IL4r, and regulatory cytokines IL5 and IL10. Female fetal sex was associated with higher postpartum IL10 in preeclamptic women only. CONCLUSIONS: We identified sexual dimorphism in maternal inflammation. Longitudinal studies are needed to determine if fetal sex impacts the maternal immune milieu across pregnancy.
OBJECTIVE: Small studies suggest that fetal sex alters maternal inflammation. We examined the association between fetal sex, preeclampsia and circulating maternal immune markers. METHODS: This was a secondary data analysis within a nested case-control study of 216 preeclamptic women and 432 randomly selected normotensive controls from the Collaborative Perinatal Project. All women had singleton, primiparous pregnancies without chronic health conditions. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for associations between female fetal sex and preeclampsia. Outcomes included preeclampsia, preterm preeclampsia (<37 and <34 weeks), and normotensive preterm birth <37 weeks. Associations between female fetal sex and immune markers [interleukin (IL)-6, IL4, IL5, IL12, IL10, IL8, IL1-beta, interferon (IFN)-gamma, tumor necrosis factor (TNF)-beta, and transforming growth factor-beta] were examined using a statistical method developed for large proportions of censored biomarker data. Models were adjusted for maternal age, race, body mass index, and smoking. RESULTS:Women with early preterm preeclampsia (<34 weeks) had higher odds of having a female fetus (ORadj. 3.2, 95% CI 1.1-9.6) and women with normotensive preterm birth had lower odds (ORadj. 0.5, 95% CI 0.3-0.9). Female fetal sex was associated with lower first trimester pro-inflammatory IFNγ and IL-12 but higher second trimester pro-inflammatory IL1β and TNFβ, anti-inflammatory IL4r, and regulatory cytokines IL5 and IL10. Female fetal sex was associated with higher postpartum IL10 in preeclamptic women only. CONCLUSIONS: We identified sexual dimorphism in maternal inflammation. Longitudinal studies are needed to determine if fetal sex impacts the maternal immune milieu across pregnancy.
Authors: Anne Cathrine Staff; Samantha J Benton; Peter von Dadelszen; James M Roberts; Robert N Taylor; Robert W Powers; D Stephen Charnock-Jones; Christopher W G Redman Journal: Hypertension Date: 2013-03-04 Impact factor: 10.190
Authors: Leslie Myatt; Christopher W Redman; Anne Cathrine Staff; Stefan Hansson; Melissa L Wilson; Hannele Laivuori; Lucilla Poston; James M Roberts Journal: Hypertension Date: 2014-03-31 Impact factor: 10.190
Authors: Gregg E Dinse; Todd A Jusko; Lindsey A Ho; Kaushik Annam; Barry I Graubard; Irva Hertz-Picciotto; Frederick W Miller; Brenda W Gillespie; Clarice R Weinberg Journal: Am J Epidemiol Date: 2014-03-04 Impact factor: 4.897
Authors: Maryam Yeganegi; Chiashan G Leung; Andrew Martins; Sung O Kim; Gregor Reid; John R G Challis; Alan D Bocking Journal: Biol Reprod Date: 2010-09-01 Impact factor: 4.285
Authors: Leah Paranavitana; Melissa Walker; Anjana Ravi Chandran; Natasha Milligan; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Lena Serghides; W Tony Parks; Ahmet A Baschat; Christopher K Macgowan; John G Sled; John C Kingdom; Lindsay S Cahill Journal: Biol Sex Differ Date: 2021-02-02 Impact factor: 5.027
Authors: José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo Journal: Colomb Med (Cali) Date: 2021-02-26
Authors: Zoe A Broere-Brown; Maria C Adank; Laura Benschop; Myrte Tielemans; Taulant Muka; Romy Gonçalves; Wichor M Bramer; Josje D Schoufour; Trudy Voortman; Eric A P Steegers; Oscar H Franco; Sarah Schalekamp-Timmermans Journal: Biol Sex Differ Date: 2020-05-11 Impact factor: 5.027
Authors: Dakshita Jagota; Hannah George; Melissa Walker; Anjana Ravi Chandran; Natasha Milligan; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Lena Serghides; W Tony Parks; Ahmet A Baschat; Christopher K Macgowan; John G Sled; John C Kingdom; Lindsay S Cahill Journal: Biol Sex Differ Date: 2021-03-10 Impact factor: 5.027
Authors: Karin Engström; Yumjirmaa Mandakh; Lana Garmire; Zahra Masoumi; Christina Isaxon; Ebba Malmqvist; Lena Erlandsson; Stefan R Hansson Journal: Toxics Date: 2021-12-06